{
    "clinical_study": {
        "@rank": "20281", 
        "brief_summary": {
            "textblock": "The purpose of this clinical research study is to assess the safety and efficacy of an\n      investigational therapy called DCVax(TM)-Prostate."
        }, 
        "brief_title": "Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.", 
        "condition": "Prostate Cancer", 
        "condition_browse": {
            "mesh_term": "Prostatic Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Patients with hormone refractory prostate cancer are eligible if they have a rising PSA or\n      three or fewer  metastatic lesions.  The experimental therapy uses a patient's own white\n      blood cells and \"teaches\" the cells to recognize a \"flag\" on prostate cancer cells.  This\n      may help the immune system destroy prostate cancer cells.  Side effects reported from the\n      Phase I/II trial include skin reactions of redness, pain & swelling at the injection site,\n      and short-lived headache, fever & fatigue.  Full details are available in the informed\n      consent."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n          -  Hormone refractory prostate cancer (HRPC) &#8211; progressive disease despite\n             androgen deprivation and serum testosterone <50ng/dL; progression defined as either:\n\n               1. Rising PSA over 6 months with at least a 50% increase between the 1st and 3rd\n                  measurement, and the 3rd measurement >2.0 ng/ml; or\n\n               2. Progression of metastatic lesion on bone scan, or\n\n               3. Progression of   lymph   node metastasis by CT scan.\n\n          -  Zubrod or ECOG performance status of 0-1.\n\n          -  Three or fewer bone metastases on a bone scan with minimal symptoms.\n\n          -  No lymph node lesions greater than 3.0 cm at longest diameter.\n\n          -  Adequate hematological, hepatic and renal function.\n\n        Exclusion Criteria\n\n          -  History of other active malignancy.\n\n          -  Prior chemotherapy, radiation therapy, immunosuppressive or investigational therapy\n             for metastatic disease in previous 12 months.\n\n          -  Strong opioids, immunosuppressives, megestrol acetate or other estrogenic hormones\n             (e.g., Saw Palmetto, PC-SPES) within 1 month prior to enrollment.\n\n          -  Brain, liver, or lung metastases; uncontrolled heart, liver, lung, or renal diseases\n             or other serious illness.\n\n          -  Prior splenectomy.\n\n          -  History of severe asthma, anaphylaxis, or other serious adverse reactions to vaccines\n             or any of the antigens included in the skin test.\n\n          -  History of moderate to severe lower limb lymphedema, or recent signs of deep venous\n             thrombosis (DVT) or thrombo-embolic disease, or impending stroke.\n\n          -  History of immunodeficiency or autoimmune disease; positive HIV, HbsAg or anti-HCV.\n\n          -  Impending untreated spinal cord compression or urinary outlet obstruction.\n\n          -  Any medication that might affect immune function. (Exceptions: Nonprescription doses\n             of NSAIDS; acetaminophen or aspirin; low doses of antihistamine therapy; normal range\n             doses of vitamins; and H2 blockers)."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "0", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 6, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00043212", 
            "org_study_id": "DC3-HRPC, October 2001"
        }, 
        "intervention": {
            "intervention_name": "Dendritic cell immunotherapy", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Hormones"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "prostate cancer", 
            "oncology", 
            "urology", 
            "hormone refractory prostate cancer"
        ], 
        "lastchanged_date": "April 30, 2013", 
        "link": {
            "description": "Northwest Biotherapeutics, Inc.", 
            "url": "http://www.nwbio.com"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Springdale", 
                        "country": "United States", 
                        "state": "Arkansas"
                    }, 
                    "name": "Highlands Oncology Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "University of California, Los Angeles"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "University of California, San Diego Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia"
                    }, 
                    "name": "Walter Reed Army Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Cancer Centers of Florida, P.A."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Peoria", 
                        "country": "United States", 
                        "state": "Illinois"
                    }, 
                    "name": "St. Francis Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }, 
                    "name": "Louisiana State University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada"
                    }, 
                    "name": "Clinical Research Solutions"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albany", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Albany Regional Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "Carolinas HealthCare System"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "Cleveland Clinic Foundation"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Mary Crowley Medical Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tyler", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Tyler Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah"
                    }, 
                    "name": "University of Utah"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Spokane", 
                        "country": "United States", 
                        "state": "Washington"
                    }, 
                    "name": "Cancer Care Northwest"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milwaukee", 
                        "country": "United States", 
                        "state": "Wisconsin"
                    }, 
                    "name": "St. Luke's Medical Center"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial Evaluating DCVax(tm)-Prostate, Autologous Dendritic Cells Loaded With Recombinant PSMA for the Treatment of Metastatic Hormone Refractory Prostate Cancer", 
        "overall_status": "Withdrawn", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00043212"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Northwest Biotherapeutics", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Northwest Biotherapeutics", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013", 
        "why_stopped": "Redirection of company goals"
    }, 
    "geocoordinates": {
        "Albany Regional Cancer Center": "42.653 -73.756", 
        "Cancer Care Northwest": "47.659 -117.426", 
        "Cancer Centers of Florida, P.A.": "28.538 -81.379", 
        "Carolinas HealthCare System": "35.227 -80.843", 
        "Cleveland Clinic Foundation": "41.499 -81.695", 
        "Clinical Research Solutions": "36.115 -115.173", 
        "Highlands Oncology Group": "36.187 -94.129", 
        "Louisiana State University": "29.951 -90.072", 
        "Mary Crowley Medical Research Center": "32.803 -96.77", 
        "St. Francis Medical Center": "40.694 -89.589", 
        "St. Luke's Medical Center": "43.039 -87.906", 
        "Tyler Cancer Center": "32.351 -95.301", 
        "University of California, Los Angeles": "34.052 -118.244", 
        "University of California, San Diego Medical Center": "32.715 -117.157", 
        "University of Utah": "40.761 -111.891", 
        "Walter Reed Army Medical Center": "38.895 -77.036"
    }
}